Sotera Health Company Common Stock

SHC's 56.3 P/E ratio is notably elevated for a healthcare services company, suggesting the market is pricing in substantial future growth or betting on margin expansion. The stock trades well below its 52-week high despite a neutral RSI of 48.9, indicating it hasn't recovered fully from recent weakness. With only 5.18% short interest, there's minimal squeeze potential, but the valuation premium relative to peers warrants scrutiny—the market either sees a compelling turnaround story or is overestimating Sotera's earnings trajectory. The current setup lacks the extremes typical of bottoms or tops, making it a middle-ground valuation puzzle rather than a clear opportunity.